 Chronic inflammation facilitates tumor progression and treatment resistance. Induction of acute inflammatory reactions often stimulates the maturation of dendritic cells and antigen presentation, leading to anti-tumor immune responses. Inflammatory metabolites including prostaglandins, leukotrenes, thromboxin, and specialized pro-resolving mediators, SPM, have been identified as pivotal regulators of the initiation and resolution of inflammation.